Brendan Shaw
Chief Executive Officer
Medicines Australia
In January 2010 Dr Brendan Shaw was appointed Chief Executive of Medicines Australia.
Brendan has been instrumental in guiding the pharmaceutical industry through reforms to the Pharmaceutical Benefits Scheme, the Pharmaceutical Benefits Advisory Committee processes and the Therapeutic Goods Administration. He has driven Medicines Australia’s research program, developed Joint Medicines Policy Conferences with the Australian Government, and Medicines Australia’s contribution to the international debate on health technology assessment.
For the last six years Dr Shaw led the Health Policy and Research function at Medicines Australia, representing the industry on the Pharmaceutical Benefits Pricing Authority, the Access to Medicines Working Group, and for two years was the industry member of the Economic Sub‑Committee of the Pharmaceutical Benefits Advisory Committee.
Dr Shaw has previously worked in academia, consulting and the Australian Government in the areas of economic development, innovation, industry analysis and public policy. He has an honours degree in economics from the University of Queensland and a PhD in management from Monash University.